As stated in one of its reports by P&S Intelligence, minimally invasive surgical instruments market is projected to touch USD 37,155.7 million by 2030, proceeding at a rate of 7.2% by the end of this decade.
Handheld instruments had the largest share of about 40% in 2022, and the situation will continue to be like this in the years to come.
This has a lot to do with the increasing acceptance of these instruments for a number of MIS surgeries, increasing acceptance of robot-assisted surgeries, and growing preference for such instruments by surgeons.
North America was the leader of the minimally invasive surgical instruments market, with a share of about 40% in 2022, and it will continue like this in the years to come.
This is due to the existence of organized healthcare systems, surge in the occurrence of diseases, for instance orthopedic and cardiac disorders, higher acceptance rate for cutting-edge devices, and shifting preference toward outpatient surgeries.
APAC will grow the fastest, powering at a rate of approximately 10% in the years to come. This is as a result of the growing cases of chronic ailments, rising elderly population, growing consciousness of people with regards to medical device outsourcing, trending medical tourism, and rise in healthcare spending.
The increasing investments in research and development in medical industry is directly proportional to the growing demand for minimally invasive surgical instruments all over the world.